1572. Conjugate Pneumococcal Vaccination Reduces Invasive Pneumococcal Disease Post Haemotopoietic Stem Cell Transplant

por Roberts, Matthew B, Hiwase, Devendra K, Bak, Narin
Publicado 2018

Solute Carrier Family 29A1 Mediates In Vitro Resistance to Azacitidine in Acute Myeloid Leukemia Cell Lines

por Kutyna, Monika M., Loone, Sophie, Saunders, Verity A., White, Deborah L., Kok, Chung H., Hiwase, Devendra K.
Publicado 2023

Impaired haematopoietic stem cell differentiation and enhanced skewing towards myeloid progenitors in aged caspase-2-deficient mice

por Dawar, Swati, Shahrin, Nur Hezrin, Sladojevic, Nikolina, D'Andrea, Richard J, Dorstyn, Loretta, Hiwase, Devendra K, Kumar, Sharad
Publicado 2016

Personalized risk model for predicting risk of acute coronary syndrome in patients with myelodysplastic syndromes

por Montarello, Natalie, Leslie, Alasdair, Chhetri, Rakchha, Friel, Oisin, Singhal, Deepak, Ross, David, Yeung, David, Kok, Chung H., Psaltis, Peter J., Hiwase, Devendra K.
Publicado 2023

A senescence stress secretome is a hallmark of therapy-related myeloid neoplasm stromal tissue occurring soon after cytotoxic exposure

por Kutyna, Monika M., Kok, Chung Hoow, Lim, Yoon, Tran, Elizabeth Ngoc Hoa, Campbell, David, Paton, Sharon, Thompson-Peach, Chloe, Lim, Kelly, Cakouros, Dimitrios, Arthur, Agnes, Hughes, Timothy, Kumar, Sharad, Thomas, Daniel, Gronthos, Stan, Hiwase, Devendra K.
Publicado 2022

Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome

por Singhal, Deepak, Kutyna, Monika M., Chhetri, Rakchha, Wee, Li Yan A., Hague, Sophia, Nath, Lakshmi, Nath, Shriram V., Sinha, Romi, Wickham, Nicholas, Lewis, Ian D., Ross, David M., Bardy, Peter G., To, Luen Bik, Reynolds, John, Wood, Erica M., Roxby, David J., Hiwase, Devendra K.
Publicado 2017

Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia

por Tiong, Ing S., Dillon, Richard, Ivey, Adam, Kuzich, James A., Thiagarajah, Nisha, Sharplin, Kirsty M., Kok, Chung Hoow, Tedjaseputra, Aditya, Rowland, James P., Grove, Carolyn S., Abro, Emad, Shortt, Jake, Hiwase, Devendra K., Bajel, Ashish, Potter, Nicola E., Smith, Matthew L., Hemmaway, Claire J., Thomas, Abin, Gilkes, Amanda F., Russell, Nigel H., Wei, Andrew H.
Publicado 2021

TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms

por Shah, Mithun Vinod, Tran, Elizabeth Ngoc Hoa, Shah, Syed, Chhetri, Rakchha, Baranwal, Anmol, Ladon, Dariusz, Shultz, Carl, Al-Kali, Aref, Brown, Anna L., Chen, Dong, Scott, Hamish S., Greipp, Patricia, Thomas, Daniel, Alkhateeb, Hassan B., Singhal, Deepak, Gangat, Naseema, Kumar, Sharad, Patnaik, Mrinal M., Hahn, Christopher N., Kok, Chung Hoow, Tefferi, Ayalew, Hiwase, Devendra K.
Publicado 2023

Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML

por de Botton, Stéphane, Fenaux, Pierre, Yee, Karen, Récher, Christian, Wei, Andrew H., Montesinos, Pau, Taussig, David C., Pigneux, Arnaud, Braun, Thorsten, Curti, Antonio, Grove, Carolyn, Jonas, Brian A., Khwaja, Asim, Legrand, Ollivier, Peterlin, Pierre, Arnan, Montserrat, Blum, William, Cilloni, Daniela, Hiwase, Devendra K., Jurcic, Joseph G., Krauter, Jürgen, Thomas, Xavier, Watts, Justin M., Yang, Jay, Polyanskaya, Olga, Brevard, Julie, Sweeney, Jennifer, Barrett, Emma, Cortes, Jorge
Publicado 2023